|
|
Volumn 88, Issue 5, 2001, Pages 488-492
|
|
A risk score system for predicting adverse outcomes and magnitude of benefit with glycoprotein IIb/IIIa inhibitor therapy in patients with unstable angina pectoris
a
a
b
c
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
FIBRINOGEN RECEPTOR ANTAGONIST;
HEPARIN;
THROMBOCYTE RECEPTOR;
TIROFIBAN;
AGED;
ANALYTIC METHOD;
ARTICLE;
CARDIOVASCULAR RISK;
CLINICAL FEATURE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CORONARY ARTERY BYPASS GRAFT;
DEPRESSION;
DISEASE SEVERITY;
HEART INFARCTION;
HEART MUSCLE ISCHEMIA;
HIGH RISK POPULATION;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
PREDICTION;
PRIORITY JOURNAL;
RISK FACTOR;
THROMBOCYTE;
TREATMENT OUTCOME;
UNSTABLE ANGINA PECTORIS;
ADULT;
AGE DISTRIBUTION;
AGED;
ANGINA, UNSTABLE;
CORONARY ANGIOGRAPHY;
DRUG THERAPY, COMBINATION;
ELECTROCARDIOGRAPHY;
FEMALE;
FOLLOW-UP STUDIES;
HEPARIN;
HUMANS;
MALE;
MIDDLE AGED;
MYOCARDIAL ISCHEMIA;
ODDS RATIO;
PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX;
PREDICTIVE VALUE OF TESTS;
PROBABILITY;
PROPORTIONAL HAZARDS MODELS;
RECURRENCE;
RISK ASSESSMENT;
RISK FACTORS;
SENSITIVITY AND SPECIFICITY;
SEVERITY OF ILLNESS INDEX;
SEX DISTRIBUTION;
SURVIVAL RATE;
TREATMENT OUTCOME;
TYROSINE;
|
|
EID: 0035451306
PISSN: 00029149
EISSN: None
Source Type: Journal
DOI: 10.1016/S0002-9149(01)01724-6 Document Type: Article |
|
Times cited : (25)
|
|
References (21)
|
